Chris Shaw

Chris Shaw is an experienced scientist with a robust background in biopharmaceutical research and development. With a Master’s in Biotechnology from The Johns Hopkins University and a Bachelor’s in Biochemistry from Virginia Polytechnic Institute and State University, Chris has held various positions in esteemed companies. From January 2016 to February 2019, Chris worked at MedImmune as a Scientist I, leading visible particle forensic investigations and developing circular dichroism techniques, and as an Associate Scientist II performing analytical testing. Previously, Chris contributed as a QC Analyst at both GlaxoSmithKline and Human Genome Sciences, and later took on senior roles at AstraZeneca, including Associate Principal Scientist and Senior Scientist, overseeing analytical activities from development to market authorization.